Globally, public healthcare systems face numerous challenges in the aftermath of the pandemic, particularly under the increasing pressure of an aging population in Western countries. The UK’s National Health Service (NHS) crisis often makes headlines. In this context, more private enterprises are recognizing market opportunities. Cera, a UK company focused on home healthcare services, has recently secured $150 million in funding, with a majority in debt. Although the company has not disclosed specific valuation and funding structure details, this round of financing was led by BDT & MSD.

In the aftermath of the pandemic, the healthcare restart efforts are facing significant challenges, particularly in the context of an aging population in Western countries. Public healthcare systems are under immense pressure, with the UK's National Health Service (NHS) frequently in crisis and making headlines. In this environment, many private companies, especially tech-driven enterprises, have identified substantial gaps in the healthcare service market. Against this backdrop, the UK-based proprietary software platform and home healthcare provider Cera has announced it has raised $150 million through debt and equity financing to further expand its operations.